Literature DB >> 29367377

Cranial neuropathy and severe pain due to early disseminated Borrelia burgdorferi infection.

Derek Ebner1, Kelsey Smith2, Daniel DeSimone3, Muhammad Rizwan Sohail3.   

Abstract

A 61-year-old man presented to the emergency department in the summer with a right seventh cranial nerve lower motor neuron palsy and worsening paraesthesias for 6 weeks. He had debilitating pain at the scalp and spine. Prior work up was unrevealing. The patient resided in the upper Midwest region of the USA and worked outdoors, optimising the landscape for white tailed deer. Repeat cerebrospinal fluid testing revealed a lymphocytic pleocytosis and positive IgM Lyme serology. Brain MRI demonstrated enhancement of multiple cranial nerves bilaterally. He was diagnosed with early Lyme neuroborreliosis and treated with 28 days of intravenous ceftriaxone. While the painful meningoradiculitis, also known as Bannwarth syndrome, is more commonly seen in Europe, facial palsy is more frequently encountered in the USA. Clinical manifestations of neuroborreliosis are important to recognise as the classic presentation varies by geography and on occasion repeat serological testing may be necessary. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  cranial nerves; infectious diseases; pain (neurology)

Mesh:

Year:  2018        PMID: 29367377      PMCID: PMC5786956          DOI: 10.1136/bcr-2017-223307

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension.

Authors:  D Bremell; L Dotevall
Journal:  Eur J Neurol       Date:  2014-03-29       Impact factor: 6.089

2.  Course and Outcome of Early European Lyme Neuroborreliosis (Bannwarth Syndrome): Clinical and Laboratory Findings.

Authors:  Katarina Ogrinc; Lara Lusa; Stanka Lotrič-Furlan; Petra Bogovič; Daša Stupica; Tjaša Cerar; Eva Ružić-Sabljić; Franc Strle
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079

3.  Neuroborreliosis.

Authors:  John J Halperin
Journal:  J Neurol       Date:  2016-11-24       Impact factor: 4.849

Review 4.  Neuroborreliosis: central nervous system involvement.

Authors:  J J Halperin
Journal:  Semin Neurol       Date:  1997-03       Impact factor: 3.420

5.  EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.

Authors:  A Mygland; U Ljøstad; V Fingerle; T Rupprecht; E Schmutzhard; I Steiner
Journal:  Eur J Neurol       Date:  2009-11-23       Impact factor: 6.089

Review 6.  Lyme Neuroborreliosis.

Authors:  Adriana R Marques
Journal:  Continuum (Minneap Minn)       Date:  2015-12

Review 7.  Prevalence and spectrum of residual symptoms in Lyme neuroborreliosis after pharmacological treatment: a systematic review.

Authors:  R Dersch; H Sommer; S Rauer; J J Meerpohl
Journal:  J Neurol       Date:  2015-10-12       Impact factor: 4.849

8.  Neuroborreliosis--an epidemiological, clinical and healthcare cost study from an endemic area in the south-east of Sweden.

Authors:  A J Henningsson; B-E Malmvall; J Ernerudh; A Matussek; P Forsberg
Journal:  Clin Microbiol Infect       Date:  2009-09-29       Impact factor: 8.067

9.  Practice parameters for the diagnosis of patients with nervous system Lyme borreliosis (Lyme disease).

Authors:  J J Halperin; E L Logigian; M F Finkel; R A Pearl
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

10.  Common and uncommon neurological manifestations of neuroborreliosis leading to hospitalization.

Authors:  Philipp Schwenkenbecher; Refik Pul; Ulrich Wurster; Josef Conzen; Kaweh Pars; Hans Hartmann; Kurt-Wolfram Sühs; Ludwig Sedlacek; Martin Stangel; Corinna Trebst; Thomas Skripuletz
Journal:  BMC Infect Dis       Date:  2017-01-21       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.